Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases

Human Gene Therapy

Volumn 11, Issue 17, 2000, Pages 2315-2329

  Alisky, J M ^a   Davidson, B L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALBINDIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE TRANSPORTER; PROTEIN BCL 2; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; AMYOTROPHIC LATERAL SCLEROSIS; GENE THERAPY; HERPES VIRUS; HUMAN; LENTIVIRINAE; MOTOR NEURON DISEASE; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; REVIEW; SPINAL MUSCULAR ATROPHY; ANIMAL; DRUG DELIVERY SYSTEM; GENE VECTOR; GENETICS; METHODOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE;

EID: 0034694007     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303400750038435     Document Type: Review

References (204)

1. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine
2. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
3. Elevated cortical extrazellular fluid glutamate in transgenic mice expressing human mutant (G93A) CuZn superoxide dismutase
4. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis
5. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors
6. Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease
7. Gene transfer into mammalian central nervous system using herpes virus vectors: Extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter
8. A simple method for the rapid generation of recombinant adenovirus vectors
9. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum
10. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: Distinct actions from those of brain-derived neurotrophic factor
11. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2
12. Prevention of mutant SOD 1 motorneuron degeneration by copper chelators in vitro
13. Identification and characterization of AFG3L2, a novel paraplegin-related gene
14. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses
15. Genetics and biology of adeno-associated virus
16. Selective and rapid uptake of adeno-associated virus type 2 in brain
17. Regulation of neural stem cell differentiation in the forebrain
18. Strumpell's familial spastic paraplegia: Genetics and neuropathology
19. Parvoviridae and their replication
20. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain
21. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
22. Adenovirus-mediated transgene expression in nonhuman primate brain
23. Characterization of adenoviral gene expression in spinal cord after remote vector delivery
24. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis
25. Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury
26. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex
27. Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells
28. Amyotrophic lateral sclerosis. Insights from genetics
29. Adenovirus gene transfer causes inflammation in the brain
30. Role of T cells in inflammation caused by adenovirus vectors in the brain
31. Glutamate uptake is decreased tardively in the spinal cord of FALS mice
32. Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome
33. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease
34. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
35. Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C
36. Cloning and characterization of adeno-associated virus type 5
37. Dopaminergic neurons protected from degeneration by GDNF gene therapy
38. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor (GDNF)
39. From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS
40. Retroviridae and their replication
41. The survival motor neuron protein in spinal muscular atrophy
42. Identification and characterization of YME1L1, a novel paraplegin-related gene
43. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
44. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
45. Comparison of pathological alterations in ALS and a murine transgenic model: Pathogenetic implications
46. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
47. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
48. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector
49. Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer
50. Recombinant AAV type 2, 4 and 5 vectors: Transduction of varient cell types and regions in the mammalian CNS
51. Time course of axotomy-induced apoptotic cell death in facial motoneurons of neonatal wild type and bct-2 transgenic mice
52. MR imaging of gene delivery to the central nervous system with an artificial vector
53. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase
54. Structural and functional heterogeneity of integrated recombinant AAV genomes
55. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death
56. Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter
57. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector
58. Experimental models of amyotrophic lateral sclerosis
59. Neurogenesis in the adult human hippocampus
60. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase
61. bcl-2 transgene expression can protect neurons against development and induced cell death
62. The use of defective herpes simplex virus amplicon vectors to modify neural cells and the nervous system
63. Specific and efficient gene transfer offers new potentialities for the treatment of motor neurone diseases
64. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis
65. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia
66. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells
67. Inhibition of ICE slows ALS in mice
68. Mammalian neural stem cells
69. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain
70. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology
71. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses
72. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
73. Systemic hyperosmolality improves β-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer
74. BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo
75. Prevention of motor neuron death by adenovirus-mediated neurotrophic factors
76. Herpes simplex virus-based vectors
77. Herpes simplex virus as a gene-delivery vector for the central nervous system
78. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats
79. Hippocampal neurogenesis in adult old world primates
80. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis
81. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
82. Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: Therapeutic effects and mechanisms of action
83. BDNF, but not NT-3, promotes long-term survival of axotomized adult rat corticospinal neurons in vivo
84. Hereditary 'pure' spastic paraplegia: A clinical and genetic study of 22 families
85. Homozygosity for Asn86Ser mutations in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis
86. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
87. Transient gene transfer to neurons and glia: Analysis of adenoviral vector performance in the CNS and PNS
88. Expression of calbindin-D(28K) in motoneuron hybrid cells after retroviral infection with calbindin-D(28K) cDNA prevents amyotrophic lateral sclerosis IgG-medinted cytotoxicity
89. The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury
90. Strumpell's pure familial spastic paraplegia: Case study and review of the literature
91. Adenoviruses
92. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis
93. Bcl-2 overexpression does not protect neurons from mutant neurofilament-mediated motor neuron degeneration
94. A mouse model for spinal muscular atrophy
95. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III
96. Amyotrophic lateral sclerosis
97. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: Analysis of 155 cases and identification of a novel insertion mutation
98. Identification of a neural stem cell in the adult mammalian central nervous system
99. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors
100. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients
101. Immune responses to adenoviral vectors during gene transfer in the brain
102. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
103. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector
104. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders
105. The use of herpes simplex virus vectors for gene therapy in neurological diseases
106. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait
107. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
108. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expended polyglutamine tract
109. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis
110. Continuation of neurogenesis in the hippocampus of the adult macaque monkey
111. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
112. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
113. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by nonhomologous recombination
114. Epidemiology of amyotrophic lateral sclerosis
115. Use of herpes simplex virus type 1 for transgene expression within the nervous system
116. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
117. Viral vectors in the treatment of Parkinson's disease
118. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo
119. Inflammatory responses in their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus
120. Multipotent neurospheres can be derived from forebrain subependymal zone and spinal cord adult mice after protracted postmortem intervals
121. Identification and characterization of a spinal muscular atrophy-determining gene
122. Correlation between severity and SMN protein level in spinal muscular atrophy
123. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
124. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
125. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins
126. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation
127. Application of recombinant adenovirus for in vivo gene delivery to spinal cord
128. Intraspinal grafting of fibroblasts genetically modified by recombinant adenoviruses
129. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus
130. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function
131. Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression
132. Long-term promoter activity during herpes simplex virus latency
133. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
134. Sporadic juvenile amyotrophic lateral sclerosis
135. Neurotensin-SPDP-poly-L-lysine conjugate: A nonviral vector for targeted gene delivery to neural cells
136. An expression system for mammalian amino acid transporters using a stably maintained episomal vector
137. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector
138. Increased expression of calbindin D28k via herpes simplex virus amplicon vector decreases calcium ion mobilization and enhances neuronal survival after hypoglycemic challenge
139. Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide
140. Review of clinical trials
141. Gene expression along the cerebral-spinal axis after regional gene delivery
142. Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression
143. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis
144. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smm(-/-) mice and results in a mouse with spinal muscular atrophy
145. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons
146. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice
147. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
148. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
149. Lentiviruses
150. Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus
151. Decrease in the ciliary neurotrophic factor of the spinal cord in amyotrophic lateral sclerosis
152. Amyotrophic lateral sclerosis: Copper/zinc superoxide dismutase (SOD1) gene mutations
153. Immunolocalization of NAIP in the human brain and spinal cord
154. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis
155. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters
156. Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults
157. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
158. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells
159. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
160. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
161. Viral vectors for gene therapy
162. Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes
163. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
164. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
165. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms
166. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
167. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
168. Gene delivery to spinal motor neurons
169. In vivo adenovirus-mediated gene transfer and expression in ischemic rabbit spinal cord
170. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement
171. Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
172. Gene transfer by naked DNA into adult mouse brain
173. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy
174. Group C adenoviruses as vectors for gene therapy
175. Adenoviridae: The viruses and their replication
176. Genetics of amyotrophic lateral sclerosis
177. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons
178. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy
179. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line
180. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum
181. Multipotent neural precursors can differentiatie toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex
182. The herpes simplex virus amplicon: Analyses of cis-acting replication functions
183. Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice
184. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clark's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats
185. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
186. Total numbers of limb motor neurones in the human lumbosacral cord and an analysis of the accuracy of various sampling procedures
187. Relative numbers of pyramidal tract neurons in mammals of different sizes
188. A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis
189. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
190. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord
191. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants
192. Expression of adenovirus-mediated E. coli lacZ gene in skeletal muscles and spinal motor neurons of transgenic mice with a mutant superoxide dismutase gene
193. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
194. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis
195. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA
196. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors
197. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
198. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets
199. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
200. Gene transfer by adeno-associated virus vectors into the central nervous system
201. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy
202. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system
203. Red nucleus neurons of Bcl-2 over-expressing mice are protected from cell death induced by axotomy
204. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo